Values as of: 2024-03-28
COMMON STOCK | Insurance - Life |
Last Closing
USD 20.5Change
0.00 (0.00)%Market Cap
USD 23.66BVolume
N/AAnalyst Target
N/AVerdict
Verdict
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| MET | MetLife Inc |
N/A |
USD 53.21B |
| AFL | Aflac Incorporated |
N/A |
USD 48.11B |
| MET-PA | MetLife Inc Preferred Stock Se.. |
N/A |
USD 46.72B |
| MFC | Manulife Financial Corp |
N/A |
USD 44.17B |
| MET-PE | MetLife Inc Preferred Stock Se.. |
N/A |
USD 41.61B |
| PRU | Prudential Financial Inc |
N/A |
USD 39.42B |
| PUK | Prudential Public Limited Comp.. |
N/A |
USD 25.10B |
| GL | Globe Life Inc |
N/A |
USD 10.94B |
| UNM | Unum Group |
N/A |
USD 10.29B |
| PRI | Primerica Inc |
N/A |
USD 7.71B |
| Market Performance vs. Industry/Classification (Insurance - Life) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 0.24% | 38% | F | 33% | F | ||
| Dividend Return | 3.09% | 94% | A | 96% | N/A | ||
| Total Return | 3.33% | 43% | F | 46% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | 11.29% | 40% | F | 56% | F | ||
| Dividend Return | 3.43% | 41% | F | 52% | F | ||
| Total Return | 14.72% | 35% | F | 54% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 36.67% | 36% | F | 64% | D | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 36.67% | 29% | F | 57% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 9.38% | 70% | C- | 56% | F | ||
| Dividend Return | 109.51% | 97% | N/A | 84% | B | ||
| Total Return | 100.14% | 96% | N/A | 92% | A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 165.86% | 9% | A- | 25% | F | ||
| Risk Adjusted Return | 66.03% | 97% | N/A | 95% | A | ||
| Market Capitalization | 23.66B | 61% | D- | 90% | A- | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The company had negative total cash flow in the most recent four quarters.
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
